Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

568
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
568
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

417
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
417
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

120
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
120
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

3.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Get Your Game Face On: Utilizing Alternative Forms of Patient Education for Cardiac Care - A Pilot Study.

Clinical nursing research·2026
Same author

Mifepristone versus placebo in the treatment of psychosis in patients with psychotic major depression.

Biological psychiatry·2006
See all related articles

Related Experiment Video

Updated: May 15, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

11.8K

Navigating Poststroke Antithrombotic Therapy Guidelines for Optimal Patient Outcomes.

Kayla Lucena-Glass1, Kimberly Wilson1, Steven Glass2

  • 1The University of Alabama, Tuscaloosa, AL, USA.

Rehabilitation Nursing : the Official Journal of the Association of Rehabilitation Nurses
|April 11, 2025
PubMed
Summary

Nurses can improve stroke prevention by understanding the latest antithrombotic therapy guidelines. Adherence to these recommendations is key for reducing stroke recurrence and improving patient outcomes.

Keywords:
Rehabilitationantithromboticembolic strokeischemic strokepharmacology

More Related Videos

Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

20.6K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.6K

Related Experiment Videos

Last Updated: May 15, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

11.8K
Prehospital Thrombolysis: A Manual from Berlin
05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

20.6K
A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model
09:42

A Fibrin-Enriched and tPA-Sensitive Photothrombotic Stroke Model

Published on: June 4, 2021

2.6K

Area of Science:

  • Neurology
  • Pharmacology
  • Nursing Education

Background:

  • Stroke is a significant and growing health concern in the United States.
  • Effective secondary prevention of stroke is critical for patient outcomes.
  • Nurses face challenges in understanding and adhering to antithrombotic therapy guidelines, impacting patient care.

Purpose of the Study:

  • To enhance nurses' understanding of antithrombotic therapy guidelines for secondary stroke prevention.
  • To provide a clear overview of the 2021 American Heart Association (AHA)/American Stroke Association (ASA) guidelines.
  • To empower nurses with knowledge for informed clinical decision-making and patient education.

Main Methods:

  • Literature review of the 2021 AHA/ASA antithrombotic therapy guidelines.
  • Summary of updated treatment and secondary prevention recommendations.
  • Inclusion of visual aids such as algorithms and pharmacological reviews.

Main Results:

  • The review provides an evidence-based pharmacological summary of the guidelines.
  • Visual aids clarify complex antithrombotic therapy algorithms.
  • The information is designed to facilitate understanding of clinical drug trials related to stroke prevention.

Conclusions:

  • Enhanced understanding of guidelines improves nurses' clinical decision-making and patient education.
  • Adherence to antithrombotic therapy guidelines can reduce stroke-related morbidity and mortality.
  • Rehabilitation nurses play a vital role in optimizing secondary stroke prevention and patient care.